Abstract
A young woman with a history of COVID-19 infection and concomitant visual problems was admitted with exacerbation of dyspnea. Upon admission, pulmonary embolism, myocarditis and fungal endocarditis were detected, probably due to persistent underlying inflammation. She underwent surgical replacement of the tricuspid valve and antifungal treatment.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study. Curr. Med. Res. Opin. 38(6), 901–909 (2022).
- 2. Late complications of COVID-19: a systematic review of current evidence. Arch. Acad. Emerg. Med. 9(1), e14 (2021).
- 3. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci. Rep. 11(1), 16144 (2021). •• A systematic review and meta-analysis about the persistent, long term or ongoing symptoms and manifestations from 14 to 110 days post-COVID-19 infection. Most prevalent one, has been fatigue and headache based on this report.
- 4. . Long-term complications of COVID-19. Am. J. Physiol. Cell Physiol. 322(1), C1–C11 (2021).
- 5. Post–COVID–19 syndrome in outpatients: a cohort study. J. Gen. Int. Med. 37(8), 1943–1952 (2022).
- 6. . Ocular manifestations of COVID-19: a systematic review and meta-analysis. J. Ophthalmic Vis. Res. 16(1), 103–112 (2021).
- 7. Uveitis and other ocular complications following COVID-19 vaccination. J. Clin. Med. 10(24), 5960 (2021).
- 8. (United TAMC, Kingdom) MMCI, Marianna Adamo (Task Force, Coordinator) (Italy) RSGTFCUK. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 1, 1–128 (2021).
- 9. . COVID-19-associated fungal infections in Iran: a systematic review. PLOS ONE 17(7), e0271333 (2022). • A systematic review with English and Persian research about fungal infections as a complication of COVID-19.
- 10. Fungal co-infection in COVID-19 patients: should we be concerned? Rev. Iberoam. Micol. 37(2), 41–46 (2020).
- 11. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm 17(9), 1463–1471 (2020).
- 12. . COVID-19 and the role of chronic inflammation in patients with obesity. Int. J. Obes. 44(8), 1790–1792 (2020).
- 13. . Multisystem inflammatory syndrome in adults: a systematic review and meta-analysis of the rheumatological spectrum of complications post COVID-19 infection. Rev. Colomb. Reumatol. 29(1), S17–S24 (2021).
- 14. Delayed-onset myocarditis following COVID-19. Lancet Respir. Med. 9(4), e32–e34 (2021).
- 15. Reported cases of multisystem inflammatory syndrome in children aged 12–20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation. Lancet Child. Adolesc. Health 6(5), 303–312 (2022).
- 16. 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play: a report of the American College of Cardiology Solution Set Oversight Committee. J. Am. Coll. Cardiol. 79(17), 1717–1756 (2022). •• A valuable expert consensus about the myocardial involvement during or after COVID-19 infection.
- 17. Case report: adult post-COVID-19 multisystem inflammatory syndrome and thrombotic microangiopathy. Front. Immunol. 12, 680567 (2021).